Evidence map›Paper›PMID 42795573›Full record

ReviewMicroorganisms2026

Saleh A Aloraini

Abstract readReview
In one paragraph

Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Saleh A AlorainiDepartment of Civil Engineering, College of Engineering, Qassim University, Buraydah 52571, Saudi Arabia.ORCID 0009-0003-2285-9457

Funding

Qassim University 2025-W-2-BSRC-119809
6 · The paper itself

Abstract

Legionnaires' disease incidence has risen substantially across industrialised nations since the early 2000s, yet standard control protocols-primarily secondary disinfection verified by culture-rely on an evidence base that warrants further scrutiny. This review offers three interpretations of the available evidence, without claiming they are established conclusions. First, culture-based verification has inherent methodological limitations: treatments that reduce culturability can induce viable-but-non-culturable (VBNC) states undetected by culture alone, creating potential discrepancies between verified culture reduction and complete microbial clearance. This reading rests on evidence that monochloramine at ≥1 mg/L abolishes culturability while genomic units remain essentially unchanged and that starved VBNC

Indexed as

biofilmdigital droplet PCRevidence appraisalLegionella pneumophilapremise plumbingsecondary disinfectionviable but non culturablewater safety plans

Identifiers

PMID42795573
PMCPMC13609631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.